Speakers
Prof. Keisuke Kida
St. Marianna University School of Medicine, Japan
Dr. Kida was born in Tokyo in January 1977. He graduated St. Marianna Medical School and obtained his M.D. in 2001 and began his residency in cardiology. He received his PhD. from St. Marianna University Graduate School in 2007, and the title of his dissertation was “Functional capacity, skeletal muscle strength, and skeletal muscle volume in patients with myocardial infarction”. He was a visiting scholar at the University of California San Diego (UCSD) until 2009.
Returning to Japan, he established the U40 heart failure network in 2013. They have conducted multicenter studies such as registry studies in acute heart failure, REALITY-AHF, and ILLUMINATE-CS in cardiac sarcoidosis. He has a wide range of research themes such as heart failure and cardiac rehabilitation.
He moved from the department of Cardiology to Pharmacology in 2018. For the past few years, he is concentrated on research in cardio-oncology.
Abstract
Cardiac rehab during COVID-19 in Japan
The impact of coronavirus disease-19 (COVID-19) on cardiac rehabilitation (CR) and guidance or recommendations on how to provide CR services were published. Several papers on COVID-19 and CR were also reported in Japan. We have previously reported on the impact of COVID-19 outbreak in Japan on the implementation of CR and how to ensure its continuation. In the second survey, 74% of facilities were unable to continue conventional group ambulatory CR; however, patients maintained their physical activity and exercise regimens and managed their illnesses with the aid of telephones and mobile devices. However, the actual number of CR patients and cardiopulmonary exercise testing (CPX) was not clear. Thus, the purpose of this survey was to clarify the time course changes of number of CR patients and CPX. In September 2021, a questionnaire survey was conducted among 37 CR training facilities in Japan. The obtained data were compiled by the Public Relations Committee of the Japanese Association of Cardiac Rehabilitation (JACR). The questionnaire survey included the total number of CR inpatients and outpatients, the number of CPX inpatients and outpatients, and the acceptance status of CR and CPX at the facilities from December 2018 to May 2021. We defined the 15 months from December 2018 through February 2020 as before COVID-19 outbreak and the 15-month period thereafter through May 2021 as during COVID-19 era. The number of inpatient CR was not impacted by the COVID-19 outbreak. On the contrary, the number of outpatient CR significantly decreased before and during COVID-19 era. The number of inpatient and outpatient CPX significantly decreased before and during COVID-19 era. The 3rd survey revealed that the number of inpatient CR was maintained regardless of COVID-19 outbreak, but outpatient CR was greatly limited, and that CPX was also more significantly impacted in outpatients, especially in the 1st wave. Since then, the number of CR and CPX has recovered but has not returned to the before COVID-19 status.